Caixin
Blue View

Blue View, Shenlanguan, produces in-depth reports and analysis for the participants in the field of biology, both industry-wise and policy-wise, with our content in pursuit pf professionalism, objectivity and prospectiveness. We provide valuable consultation of industrial strategies, and at the same time, target on pushing boundaries of the policy-making and the technological innovation of the healthcare industry.

COLUMNISTS
  • Opinion_ver1

    Ling Huawei
  • Opinion_ver1

    Barry Eichengreen
  • Opinion_ver1

    He Yafei
  • Opinion_ver1

    Andrew Sheng
  • Opinion_ver1

    Keyu Jin
  • Opinion_ver1

    Shen Jianguang
  • Opinion_ver1

    Wang Tao
  • Opinion_ver1

    Sheng Songcheng
  • Opinion_ver1

    Ken Fisher
  • Opinion_ver1

    Yu Yongding
  • Opinion_ver1

    Zhang Jun
  • Opinion_ver1

    Li Yan
  • Opinion_ver1

    Joel Gallo
  • Opinion_ver1

    Hong Hao
  • Opinion_ver1

    Edward Tse
  • Opinion_ver1

    Zhu Huaxin
  • Opinion_ver1

    Caixin Insight
  • Opinion_ver1

    CDRF
  • Opinion_ver1

    Blue View
  • Opinion_ver1

    Rao Yi
  • Opinion_ver1

    Lu Zhenhua